Moreover, in some patients the CD19 downregulation is accompanied by decreased expression of other surface antigens, such as CD20 and CD22 in B-ALL [98] and similarly CD20, CD22, and CD79a in lymphomas [99,100]. Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.